Kiwi Constipation Randomized Trial: What the Evidence Says

Quick Answer

Kiwi Constipation Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 observational study, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• While IBS is not linked with significant mortality, the associated medical and psychiatric morbidity is highly prevalent. [Kaye Alexander J. (2026); evidence level 3]
• Supplement 1 The online survey consisted of the IBS-Subject's Global Assessment (IBS-SGA), visual analog scale for IBS (VAS-IBS), and the Food Avoidance subscale of IBS quality of life (IBS-QoL).,,Clinical significance was defined as a change of 30% or more from baseline based on industry guidelines.The questions derived from these questionnaires and their associated scoring systems are displayed in. [Kaye Alexander J. (2026); evidence level 3]
• Functional constipation is predominantly characterized by impaired colonic propulsion and reduced stool hydration, often associated with delayed transit and diminished postprandial motor responses. [Ribichini Emanuela (2026); evidence level 4]
• Lembo, 2016 Sadeghi et al., 2023 Physiological and transit studies highlight the marked heterogeneity of CC, which may present with normal or delayed colonic transit and with different motor patterns, ranging from reduced propulsive activity to increased segmental tone. [Ribichini Emanuela (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For kiwi constipation randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Kaye Alexander J. (2026). FODMAP-Targeting Digestive Enzyme Blend for Management of Gastrointestinal Symptoms: A “Real-World” Pre-Post Intervention Cohort Study. DOI: 10.1016/j.gastha.2026.100898. PMCID: PMC13018943. PMID: 41908325. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13018943/
• Ribichini Emanuela (2026). Dietary strategies for chronic constipation: smartly targeting hormonal and reflex pathways for optimal recovery. DOI: 10.3389/fphar.2026.1738562. PMCID: PMC12957248. PMID: 41788803. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12957248/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.